← Back to all trials
Active Not Recruiting
NCT07308392
Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
Conditions: Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 119
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Location: The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing Jiangsu
Summary
Phase II clinical trial evaluating the efficacy and safety of HRS-7249 and SHR-1918 in patients with severe hypertriglyceridemia at high risk of acute pancreatitis
Eligibility Criteria
Inclusion Criteria:
1. Understand the research procedures and methods, voluntarily participate in this trial, and sign the informed consent form in writing;
2. Male or female aged ≥18 years and \
Source: ClinicalTrials.gov (NCT07308392). StuddyBuddy aggregates publicly available trial information.
